New subcutaneous formulation of Tysabri approved in UK
Multiple sclerosis treatment can now be administered subcutaneously or intravenously
16th April 2021
Latest news
EMA begins review of GSK/Vir’s COVID-19 antibody
The review will include an interim analysis of efficacy and safety data from the Phase III COMET-ICE trial
16th April 2021
Roche’s SMA treatment Evrysdi demonstrates continued improvements in infants
Drug continuously improved motor function and survival in babies after 24 months of treatment
16th April 2021
NICE recommends Alexion’s PNH treatment Ultomiris
C5 complement inhibitor approved to treat PNH in adult patients with haemolysis
16th April 2021
Alchemab completes £60m Series A funding to advance novel antibody platform
The funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics
15th April 2021
Magic mushroom compound psilocybin shows ‘promise’ in depression
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting
15th April 2021
Amylyx Pharma plans to file ALS therapy with the EMA this year
The previously-reported CENTAUR study of AMX0035 in 137 participants with ALS met its primary endpoint of slowing ALS progression
15th April 2021
GSK decides to halt mid-stage feladilimab studies
British drugmaker has discontinued treatment with investigational drug in two cancer trials
15th April 2021
Pfizer, Myovant begin dosing in relugolix contraceptive study
Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet
14th April 2021
Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer
US Food and Drug Administration approved antibody drug conjugate based on Phase II trial results
14th April 2021
NICE publishes new guidance on chronic pain management
Guidelines recommend exercise programmes and psychological therapies rather than commonly used drugs
14th April 2021
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded
Trial will now include vaccines developed by Moderna and Novavax
14th April 2021
Antibiotic Research UK launches small research grants programme
Charity will award grants for research projects into antibiotics and antibiotic resistance
13th April 2021
Experts call for advanced radiotherapy funding to address COVID-19 cancer care backlog
Cancer experts urge the government to address funding gaps for high-precision radiotherapy
13th April 2021
Inhaled asthma drug accelerates recovery from COVID-19
Self-reported recovery was three days shorter for patients receiving inhaled budesonide
13th April 2021
